Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
11629 results
-
Support at Home – Template for service agreements
A template to assist in-home aged care providers on service agreements for the Support at Home program. -
Electronic National Residential Medication Charts (eNRMC) – Transition to electronic prescribing and end of Transitional Agreement
This document provides an overview of the revised timeframes for eNRMC systems to achieve electronic prescribing conformance and for aged care services to transition. -
Electronic National Residential Medication Chart (eNRMC) – Key dates for eNRMC electronic prescribing transition
The Department of Health, Disability and Ageing and the Australian Digital Health Agency have worked closely with software vendors over the past 3 years to develop electronic prescribing capabilities and enhanced safety features within eNRMC systems. -
Electronic National Residential Medication Charts (eNRMC) – Pharmacist fact sheet
The Department of Health, Disability and Ageing and the Australian Digital Health Agency are working with eNRMC software vendors to ensure electronic prescribing enabled eNRMC systems are available by 1 October 2025. -
Electronic National Residential Medication Chart (eNRMC) – Aged Care fact sheet
This document provides an update for residential aged care services on the availability of conformant eNRMC systems by October 2025, which include electronic prescribing capabilities and enhanced safety features. -
Electronic National Residential Medication Charts (eNRMC) – Prescriber fact sheet
This document provides information for prescribers about the rollout of electronic prescribing conformant eNRMC systems in residential aged care, including the various types of eNRMC systems they may encounter during the transition phase. -
Life Saving Drugs Program (LSDP) Expert Panel meeting agenda – 31 October 2025
Life Saving Drugs Program (LSDP) Expert Panel (the panel) agenda for the 22nd meeting on 31 October 2025. -
GPMS – About GPMS
This video explains what GPMS is, why it was developed and how it supports aged care providers, workers and older Australians. -
Schedule of contributions for Support at Home services
This schedule applies to people receiving care through the Support at Home program from 1 November 2025. -
Rural Procedural Grants Program guidelines
These guidelines outline how the Rural Procedural Grants Program works, who is eligible, and roles and responsibilities. -
GPMS – Editing access roles
Learn how to locate users, update their roles, manage access to homes and branches, and ensure secure and accurate role assignments. -
GPMS – Logging into the portal
Learn how to access the Approved and Registered Provider Portals, choose between VANguard or myID authentication, and complete the initial login process including accepting Terms of Use and verifying your identity. -
Changes coming to care minutes funding
This fact sheet provides information for non-specialised metropolitan residential aged care providers on upcoming changes to care minutes funding. -
GPMS – Adding users
This step-by-step video guides organisation administrators through adding users at both the organisation and provider levels, assigning appropriate access roles, and managing user records. -
Care minutes in aged care homes
This fact sheet helps older persons, their families and carers understand the care minutes requirement for residential aged care. -
Care minutes and 24/7 registered nurse responsibilities – guides for residential aged care providers
These guides provide information about the mandatory care minutes and 24/7 registered nurse responsibilities. Learn more about each responsibility, including delivery of care minutes and registered nurse coverage and reporting obligations. -
Thriving Kids Advisory Group communique – September 2025
This communique is published following each meeting of the Thriving Kids Advisory Group. It summarises the meeting discussions and outcomes. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Guidelines
These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for acid sphingomyelinase deficiency (ASMD) types A/B and B under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Acid sphingomyelinase deficiency (ASMD) types A/B and B
A collection of resources for health professionals to help people with acid sphingomyelinase deficiency (ASMD) types A/B and B access olipudase alfa (Xenpozyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Initial application
Treating physicians use this application form to apply for a patient to access LSDP medication for ASMD types A/B and B for the first time, or after a break. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Reapplication
Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for ASMD types A/B and B. -
Life Saving Drugs Program – Acid sphingomyelinase deficiency (ASMD) types A/B and B – Patient test results spreadsheet
Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program. -
Registered nurse coverage in residential aged care dashboard
This dashboard provides users with high level information on 24/7 registered nurse coverage in residential aged care. -
24/7 registered nurses in aged care homes
This fact sheet helps older persons, their families and carers understand the 24/7 registered nurse responsibility for residential aged care. -
Changes in financial reporting from 1 November 2025 – Video
This is a recording of the Changes in financial reporting from 1 November 2025 webinar held on 23 September 2025.